BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12352240)

  • 1. Extent of nodal involvement in Stage III colorectal carcinoma: relationship to clinicopathologic variables and genetic alterations.
    Elsaleh H; Cserni G; Iacopetta B
    Dis Colon Rectum; 2002 Sep; 45(9):1218-22. PubMed ID: 12352240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.
    Westra JL; Schaapveld M; Hollema H; de Boer JP; Kraak MM; de Jong D; ter Elst A; Mulder NH; Buys CH; Hofstra RM; Plukker JT
    J Clin Oncol; 2005 Aug; 23(24):5635-43. PubMed ID: 16110022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinicopathologic characteristics and genetic alterations between microsatellite instability-positive and microsatellite instability-negative sporadic colorectal carcinomas in patients younger than 40 years old.
    Suh JH; Lim SD; Kim JC; Hong SH; Kang GH
    Dis Colon Rectum; 2002 Feb; 45(2):219-28. PubMed ID: 11852336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.
    Elsaleh H; Powell B; McCaul K; Grieu F; Grant R; Joseph D; Iacopetta B
    Clin Cancer Res; 2001 May; 7(5):1343-9. PubMed ID: 11350904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancer.
    Wang C; van Rijnsoever M; Grieu F; Bydder S; Elsaleh H; Joseph D; Harvey J; Iacopetta B
    Oncology; 2003; 64(3):259-65. PubMed ID: 12697967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
    Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
    Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between genetic alterations and prognosis in sporadic colorectal cancer.
    Chang SC; Lin JK; Yang SH; Wang HS; Li AF; Chi CW
    Int J Cancer; 2006 Apr; 118(7):1721-7. PubMed ID: 16231316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma.
    Elsaleh H; Iacopetta B
    Clin Colorectal Cancer; 2001 Aug; 1(2):104-9. PubMed ID: 12445368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas.
    Hasegawa A; Fukushima T; Mashiko M; Nakano K; Suzuki S; Endo Y; Ohki S; Hatakeyama Y; Koyama Y; Inoue N; Takebayashi Y; Sekikawa K; Takenoshita S
    Anticancer Res; 2004; 24(3b):2047-52. PubMed ID: 15274399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
    Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
    Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer.
    Pucciarelli S; Agostini M; Viel A; Bertorelle R; Russo V; Toppan P; Lise M
    Dis Colon Rectum; 2003 Mar; 46(3):305-12. PubMed ID: 12626904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
    Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
    Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
    Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
    Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-ras gene mutations, LOH of the APC and DCC genes, and microsatellite instability in primary colorectal carcinoma are not associated with micrometastases in pericolonic lymph nodes or with patients' survival.
    Zauber NP; Wang C; Lee PS; Redondo TC; Bishop DT; Goel A
    J Clin Pathol; 2004 Sep; 57(9):938-42. PubMed ID: 15333653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.
    Einspahr JG; Martinez ME; Jiang R; Hsu CH; Rashid A; Bhattacharrya AK; Ahnen DJ; Jacobs ET; Houlihan PS; Webb CR; Alberts DS; Hamilton SR
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1443-50. PubMed ID: 16896030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
    Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
    Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
    Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer.
    Tortola S; Marcuello E; González I; Reyes G; Arribas R; Aiza G; Sancho FJ; Peinado MA; Capella G
    J Clin Oncol; 1999 May; 17(5):1375-81. PubMed ID: 10334521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
    Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R
    J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.